Adaptimmune
Clinical trials sponsored by Adaptimmune, explained in plain language.
-
Engineered immune cells take on advanced lung cancer in early trial
Disease control CompletedThis early-phase study tested a new treatment for people with advanced non-small cell lung cancer that had grown or returned after standard therapy. Researchers took participants' own immune cells, modified them in a lab to better recognize and attack cancer, and infused them bac…
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Engineered t cells take aim at Hard-to-Treat cancers in early trial
Disease control CompletedThis early-stage study tested a new treatment for people with advanced bladder, skin (melanoma), or head and neck cancers. Doctors took patients' own immune cells, modified them in a lab to better recognize and attack cancer cells, and then infused them back. The main goal was to…
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated May 22, 2026 13:53 UTC